Zur Rose Group AG, a leading player in the European healthcare sector, is headquartered in Frauenfeld, Switzerland. Founded in 1993, the company has established itself as a prominent online pharmacy and healthcare provider, primarily serving Switzerland and Germany. Specialising in the distribution of pharmaceuticals, health products, and medical supplies, Zur Rose Group AG distinguishes itself through its innovative e-commerce platform and a commitment to customer-centric services. The company has achieved significant milestones, including its successful public listing in 2019, which has bolstered its market position. With a focus on digital transformation in healthcare, Zur Rose Group AG continues to enhance its offerings, making it a key competitor in the rapidly evolving online pharmacy landscape. Its dedication to quality and accessibility has earned it a notable reputation among consumers and healthcare professionals alike.
How does Zur Rose Group AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Zur Rose Group AG's score of 30 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2022, Zur Rose Group AG reported total carbon emissions of approximately 41.4 million tonnes CO2e. This figure includes about 2.0 million tonnes from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and approximately 3.4 million tonnes from Scope 2 emissions, primarily related to purchased electricity and heat. The company also recorded significant Scope 3 emissions, totalling around 35.9 million tonnes CO2e, which include indirect emissions from the supply chain and other activities. In 2021, the total emissions were about 3.97 million tonnes CO2e, with Scope 1 emissions at approximately 810,000 tonnes and Scope 2 emissions around 3.16 million tonnes. The Scope 3 emissions for that year were not fully detailed but included business travel emissions of about 158,760 tonnes CO2e. Zur Rose Group AG has not publicly committed to specific reduction targets or initiatives as part of recognised frameworks such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of defined reduction targets suggests that the company may still be in the early stages of formalising its climate commitments. Overall, while the company has made strides in tracking its emissions, further clarity on reduction strategies and commitments would enhance its sustainability profile in the pharmaceutical and healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2020 | 2021 | 2022 | |
---|---|---|---|
Scope 1 | 773,000 | 000,000 | 0,000,000 |
Scope 2 | 3,130,000 | 0,000,000 | 0,000,000 |
Scope 3 | 25,550,000 | 000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zur Rose Group AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.